Farther Finance Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$788K Buy
3,649
+52
+1% +$9.95K 0.01% 1243
2026
Q1
$661K Buy
3,597
+1,941
+117% +$358K 0.01% 1211
2025
Q4
$291K Buy
1,656
+607
+58% +$99.2K ﹤0.01% 1662
2025
Q3
$147K Buy
1,049
+94
+10% +$12.7K ﹤0.01% 1800
2025
Q2
$120K Sell
955
-172
-15% -$21.4K ﹤0.01% 1669
2025
Q1
$149K Sell
1,127
-468
-29% -$66.9K ﹤0.01% 1347
2024
Q4
$244K Sell
1,595
-6,061
-79% -$1.02M 0.01% 897
2024
Q3
$1.48M Buy
7,656
+160
+2% +$33.5K 0.06% 255
2024
Q2
$1.74M Buy
7,496
+426
+6% +$92.6K 0.08% 188
2024
Q1
$1.52M Sell
7,070
-126
-2% -$29.5K 0.09% 186
2023
Q4
$1.86M Buy
7,196
+6,018
+511% +$1.48M 0.13% 141
2023
Q3
$303K Buy
1,178
+844
+253% +$226K 0.05% 290
2023
Q2
$95.1K Buy
334
+145
+77% +$43.2K 0.02% 479
2023
Q1
$52.5K Buy
189
+14
+8% +$3.87K 0.02% 590
2022
Q4
$48.5K Buy
+175
New +$49.4K 0.02% 494

Other funds holding BIIB

Farther Finance Advisors's BIIB Position: Q2 2026 in Review

Farther Finance Advisors increased its Biogen (BIIB) stake by 1.4% in Q2 2026, buying an estimated $9.95K and bringing the position to 3,649 shares worth $788K. The position accounts for 0.01% of the portfolio, ranked #1243.

Farther Finance Advisors first reported a position in BIIB in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.86M in Q4 2023. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Farther Finance Advisors held 3,649 shares of Biogen worth $788K as of Q2 2026.
  • Farther Finance Advisors bought 52 Biogen shares in Q2 2026, an estimated $9.95K.
  • Biogen made up 0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #1243 holding.
  • Farther Finance Advisors first reported a position in Biogen in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Biogen position peaked at $1.86M in Q4 2023.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.